Oragenics Announces Positive Data on Intranasal COVID-19 Vaccine Candidate
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read more
vaccine development
Moderna’s ‘Spikevax’ COVID-19 Vaccine Gets Full FDA Approval
The U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read more
Pfizer and BioNTech Launch Omicron-specific COVID Vaccine Trial
Pfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read more
Moderna Says its Booster Increases Omicron Neutralizing Antibody Levels
Vaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read more
Vaccine Makers Pledge Fast Response Against Omicron Variant
Leading vaccine producers have stated that new vaccines will be developed if necessary to meet the demand of governments worldwide
Read more
Emergex to Launch Phase I Trial for New T-Cell Priming COVID-19 Vaccine
A next-generation COVID-19 vaccine, developed by British biotech Emergex, designed to prime T-Cells to rapidly remove viral-infected cells and offer
Read more
FDA Panel in Favor of Pfizer’s COVID-19 Vaccine for Children Aged 5 to 12
The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted 17 to 0,
Read more
Valneva’s COVID-19 Vaccine Candidate Shows Positive Results in Phase 3 Trial
French pharmaceutical company Valneva has reported positive results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 in the Phase 3
Read more
Pfizer and BioNTech Submit Initial Trial Data from COVID-19 Vaccine Phase 2/3 Study in Children to the FDA
Pfizer and BioNTech reported that data from their COVID-19 vaccine Phase 2/3 study in children aged 5 to 12 years
Read more
Pfizer-BioNTech COVID-19 Vaccine First to be Fully Approved by the FDA
The U.S. Food and Drug Administration announced on Monday it has approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine which will
Read more